Second generation basal insulin in advancing T2D therapy

Overview

Highlights on the second generation basal insulins and its rich wall of clinical evidences in different patients profile focusing special population and the great benefits in the hypoglycemia in different definitions

This Class for

• Clinical Pharmacy
• Pharmacy
• Physician
• Resident / Fellow

Related Classes

• Targeting multiple pathways
• Post-GLP Podcast: needs of patients on GLP-1 RA with basal insulin
• Soliqua and Unmet Needs Webinar Summary - William Polonsky and Kathrine
• Timely insulin initiation to limit disease progression
• SURMOUNT-5 Clinical Update–Now Published
• Bridging pathophysiology and epidemiology for better understanding of obesity
• Introducing Mounjaro: A Once-Weekly, First-in-Class GIP and GLP-1 Receptor Agonist
• Supporting Patients with Obesity Through Comprehensive Treatment